DANYELZA®

DANYELZA®

DANYELZA
(naxitamab-gqgk) 40mg/10mL Injection
Please click for full Prescribing Information and Patient Information for DANYELZA including BOXED WARNING on serious infusion-related reactions and neurotoxicity.

MORE INFO


Y-mAbs ConnectTM provides answers to questions related to access, insurance, financial support programs and other resource programs for qualifying patients.

Find out about access and reimbursement support for DANYELZA

Y-mAbs Connect